HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New immune therapy tested for HPV-Linked throat cancer
Disease control Not yet recruitingThis study is testing a new immune therapy called CUE-101, both alone and combined with an existing drug (pembrolizumab), as a treatment given before surgery for advanced head and neck cancer caused by HPV-16. It will involve about 30 people with newly diagnosed cancer that canno…
Matched conditions: HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Could less radiation mean fewer side effects for throat cancer patients?
Disease control Not yet recruitingThis study is testing whether using a lower dose of radiation to healthy-looking areas around throat tumors can be just as effective as standard treatment while reducing side effects. The trial will enroll 31 adults with HPV-positive throat cancer who are scheduled for standard c…
Matched conditions: HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Sara Medek • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Could less radiation mean fewer side effects for throat cancer patients?
Disease control Not yet recruitingThis study is testing whether doctors can safely lower radiation doses for people with HPV-positive throat cancer to reduce side effects while still keeping the cancer under control. It will enroll 132 adults who are having either surgery followed by radiation or radiation as the…
Matched conditions: HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC